Skip to content

Integra LifeSciences IART Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$3.1B-10.7%
Boston Scientific logo
Boston ScientificBSX
$2.51B+6.8%
Globus Medical logo
Globus MedicalGMED
STERIS logo
STERISSTE
ITG
Integer HoldingsITGR
Merit Medical Systems logo
Merit Medical SystemsMMSI

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B-56.8%
Enterprise value$3.12B-26.7%
P/S0.8×-1.1×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's accrued liabilities, current?
Integra LifeSciences (IART) reported accrued liabilities, current of $133.32M in Q1 2026.
How has Integra LifeSciences's accrued liabilities, current changed year-over-year?
Integra LifeSciences's accrued liabilities, current decreased by 3.0% year-over-year, from $137.42M to $133.32M.
What is the long-term trend for Integra LifeSciences's accrued liabilities, current?
Over 5 years (2020 to 2025), Integra LifeSciences's accrued liabilities, current has grown at a 6.7% compound annual growth rate (CAGR), from $94.19M to $130.49M.